|Bid||0.00 x 1300|
|Ask||0.00 x 1000|
|Day's Range||164.55 - 167.85|
|52 Week Range||103.76 - 167.85|
|Beta (3Y Monthly)||1.49|
|PE Ratio (TTM)||43.35|
|Earnings Date||Feb 25, 2020 - Mar 2, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||156.82|
Is Amedisys Inc (NASDAQ:AMED) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research on a given stock. Although there have been several high profile failed hedge fund picks, the consensus picks among hedge fund investors have historically outperformed the market after adjusting […]
The best health care stocks to watch have several commonalities including a streak of earnings growth. It's important to keep tabs on high-ranking health care stocks with strong metrics.
When Amedisys, Inc.'s (NasdaqGS:AMED) announced its latest earnings (30 September 2019), I wanted to understand how...
Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Richard Herman Driehaus used the "buy high and sell higher" rule to create an investment approach, which appeals to those having a high level of risk appetite.
Amedisys, Inc. (AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire Asana Hospice. Under the terms of the agreement, targeted to close on January 1, 2020, Amedisys will acquire 100 percent of the ownership interests in Asana Hospice. Asana provides hospice care to approximately 540 patients daily in eight locations in Pennsylvania, Ohio, Missouri, Kansas and Texas.
Amedisys (AMED) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Amedisys, Six Flags Entertainment, Target, Walmart and Disney highlighted as Zacks Bull and Bear of the Day
Amedisys, Inc. (AMED), one of America's leading home health, hospice and personal care companies, today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 2019 Jefferies London Healthcare Conference in London, England on Wednesday, November 20, 2019. Amedisys, Inc. is a leading healthcare at home company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life.
BOULDER Colo., Nov. 12, 2019 /PRNewswire/ -- nVoq, a leading provider of HIPAA compliant speech recognition solutions for the healthcare industry, is pleased to announce its partnership with Amedisys, Inc. (AMED), America's leading independent home health, hospice and personal care company. The partnership will leverage nVoq's innovative technology platform, which supports both mobile and care center-based clinicians, within Amedisys' home health and hospice footprint spanning 38 US states and over 300 locations. "Amedisys is committed to providing our caregivers with the right tools to offer the best possible care for our patients," said Chris Gerard, Amedisys, Chief Operating Officer.
Amedisys Inc. (AMED), a leading independent home health, hospice and personal care company, is taking the opportunity on this Veteran’s Day to expand its commitment to honor America’s dying military veterans with the highest quality end-of-life care. The company, as the nation’s third largest hospice provider, is pledging that all of its 137 hospice care centers nationwide by next year will partner with the “We Honor Veterans” program, a collaboration between the U.S. Department of Veteran Affairs and the National Hospice and Palliative Care Organization. The Company currently has 90 percent of its hospice care centers engaged in the We Honor Veterans program.